Wegovy tablets have been studied in the OASIS clinical trial programme
Individual results vary significantly
The cost-effectiveness of subcutaneous semaglutide versus empagliflozin in type 2 diabetes uncontrolled on Metformin Alone in Denmark
Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Taking the time to verify your benefits and work with your doctor to document medical necessity can make a big difference in getting the support you need for your health journey
Several factors may contribute to lower energy levels during workouts, including: Reduced calorie intake Low carbohydrate intake Dehydration Electrolyte imbalance Poor sleep Rapid weight loss Not eating enough protein Some individuals unintentionally eat far too little because appetite suppression becomes very strong